TRDA - Entrada Therapeutics, Inc.

Insider activity in TRDA over the last quarter tilts toward selling: insiders offloaded a net 1,209,960 shares worth roughly $8.7M.

Classified under Biotechnology (Health Care sector), TRDA's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Baker Bros. Advisors LP	4.69M	$42.55M	-
10%	Mpm Bioventures 2018, L.P.	3.89M	$27.70M	-
10%	Mpm Bioventures 2014, L.P.	3.89M	$27.70M	-
10%	5am Ventures V, L.P.	2.78M	$19.07M	-
Dir	Parmar Kush	2.69M	$18.84M	-

Buys and sells only

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 20, 2025	Baker Bros. Advisors LP59	10% Owner	Buy	28,867	$9.07	$261,846.12	+0.6%	+20.4%	-
Nov 14, 2025	5am Ventures V, L.P.62	10% Owner	Sell	200,000	$8.80	$1,760,000.00	-6.3%	+23.4%	-
Nov 14, 2025	Parmar Kush62	Director, 10% Owner	Sell	200,000	$8.80	$1,760,000.00	-6.3%	+23.4%	-
Nov 12, 2025	Baker Bros. Advisors LP59	10% Owner	Buy	178,044	$7.60	$1,352,586.68	+4.0%	+35.1%	-
Jul 9, 2025	Parmar Kush62	Director, 10% Owner	Sell	27,000	$7.50	$202,554.00	-2.4%	-22.7%	-
Jul 9, 2025	5am Ventures V, L.P.62	10% Owner	Sell	27,000	$7.50	$202,554.00	-2.4%	-22.7%	-
Jul 1, 2025	Parmar Kush62	-	Sell	125,000	$6.93	$866,632.50	-10.2%	-17.9%	+6.8%
Jul 1, 2025	5am Ventures V, L.P.62	-	Sell	125,000	$6.93	$866,632.50	-10.2%	-17.9%	+6.8%
Mar 17, 2025	Wentworth Kory James61	Chief Financial Officer	Sell10b5-1	1,784	$10.67	$19,035.28	-1.6%	-31.5%	+16.5%
Dec 11, 2024	Mpm Bioventures 2018, L.P.54	10% Owner	Sell	44,722	$20.51	$917,110.96	-1.0%	-46.5%	-45.7%